Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+

Name: Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+
License: Public Domain

Nantes University Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

acute lymphoblastic leukemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 180365
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.